Patients with claudication have a marked impairment in exercise performance. Several factors contribute to this limitation, including reductions in large vessel blood flow and oxygen delivery as well as metabolic abnormalities in skeletal muscle. The relative contribution of these factors and their role in the pathophysiology of the exercise limitation is discussed using a point-counterpoint approach. Future directions for research conclude the discussion.
Bylund AC, Hammarsten J, Holm J, Schersten T.Enzyme activities in skeletal muscles from patients with peripheral arterial insufficiency. Eur J Clin Invest1976; 6:425-429.
2.
Jansson E, Johansson J, Sylven C, Kaijser L.Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol1988; 8: 17-29.
3.
Lundgren F, Dahllof AG, Schersten T, Bylund-Fellenius AC.Muscle enzyme adaptation in patients with peripheral arterial insufficiency: spontaneous adaptation, effect of different treatments and consequences on walking performance. Clin Sci (Lond)1989; 77: 485-493.
4.
Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP.Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol1996; 81:780-788.
5.
Wibom R, Hultman E, Johansson M, Matherei K, Constantin-Teodosiu D, Schantz PG.Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol1992; 73: 2004-2010.
6.
Wang H, Hiatt WR, Barstow TJ, Brass EP.Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol1999; 80:22-27.
7.
Heddi A, Stepien G, Benke PJ, Wallace DC.Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. JBiol Chem1999; 274:22968-22976.
8.
Fosslien E.Mitochondrial medicine molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci2001; 31:25-67.
Barker GA, Green S, Green AA, Walker PJ.Walking performance, oxygen uptake kinetics and resting muscle pyruvate dehydrogenase complex activity in peripheral arterial disease. Clin Sci (Lond)2004; 106: 241-249.
11.
Hiatt WR, Nawaz D, Brass EP.Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol1987; 62: 2383-2387.
12.
Pentecost BL.The effect of exercise on the external iliac vein blood flow and local oxygen consumption in normal subjects, and in those with occlusive arterial disease. Clin Sci1964; 27:437-445.
13.
Hlavova J, Linhart J, Prerovsky I, Ganz V, Fronek A.Leg blood flow at rest, during and after exercise in normal subjects and in patients with femoral artery occlusion. Clin Sci1965; 29: 555-564.
14.
Hillestad LK.The peripheral blood flow in intermittent claudication. IV. The significance of the claudication distance. Acta Med Scand1963; 173: 467-478.
15.
Bartoli V, Dorigo B.Comparison between reactive and exercise hyperemia in normal subjects and patients with peripheral arterial disease. Angiology1979; 30:40-47.
16.
Corsi C, Pollastri M, Marrapodi E, Leanza D, Giordano S, D’Iddio S.L-propionylcarnitine effect on postexercise and postischemic hyperemia in patients affected by peripheral vascular disease. Angiology1995; 46: 705-713.
17.
Neumann FJ, Waas W, Diehm C, et al.Activation and decreased deformability of neutrophils after intermittent claudication. Circulation1990; 82: 922-929.
18.
Belch JJ, Mackay IR, Hill A, Jennings P, McCollum P.Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus. Int Angiol1995; 14: 385-388.
19.
Bhat HK, Hiatt WR, Hoppel CL, Brass EP.Skeletalmusclemitochondrial DNA injury in patients with unilateralperipheralarterialdisease. Circulation1999; 99: 807-812.
20.
Rouslin W.Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol1983; 244: H743-H748.
21.
Rouslin W, Ranganathan S.Impaired function of mitochondrial electron transfer complex I in canine myocardial ischemia: loss of flavin mononucleotide. J Mol Cell Cardiol1983; 15: 537-542.
22.
Lesnefsky EJ, Hoppel CL.Ischemia reperfusion injury in the aged heart: role of mitochondria. Arch Biochem Biophys2003; 420:287-297.
23.
Richter C, Gogvadze V, Laffranchi R, et al.Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta1995; 1271:67-74.
24.
Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ.The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem1990; 265:16330-16336.
25.
Ames BN, Shigenaga MK, Hagen TM.Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A1993; 90: 7915-7922.
26.
Brass EP, Hiatt WR, Gardner AW, Hoppel CL.Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease. Am J Physiol Heart Circ Physiol2001; 280: H603-H609.
27.
Pipinos II, Sharov VG, Shepard ADet al.Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. J Vasc Surg2003; 38:827-832.
28.
Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ.Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem2003; 278: 36027-031.
29.
Wang Y, Fang J, Leonard SS, Krishna Rao KM.Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radic Biol Med2004; 36: 1434-1443.
30.
Whipp BJ, Ward SA, Lamarra N, Davis JA, Wasserman K.Parameters of ventilatory and gas exchange dynamics during exercise. J Appl Physiol1982; 52: 1506-1513.
31.
Auchincloss JH Jr, Meade JW, Gilbert R, Chamberlain BE.One minute oxygen uptake in peripheral ischemic vascular disease. Ann Surg1980; 191:203-206.
32.
Bauer TA, Regensteiner JG, Brass EP, Hiatt WR.Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease. J Appl Physiol1999; 87: 809-816.
33.
Bauer TA, Brass EP, Nehler MR, Barstow TJ, Hiatt WR.Pulmonary vO2 dynamics during treadmill and arm exercise in peripheral arterial disease. J Appl Physiol2004; 97: 627-634.
34.
Kemp GJ, Thompson CH, Taylor DJ, Hands LJ, Rajagopalan B, Radda GK.Quantitative analysis of defects of mitochondrial oxidation during recovery from exercise. Biochem Soc Trans1993; 21: 176 S-176 S.
35.
Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD.Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. J Vasc Surg2000; 31:944-952.
36.
Green S, Bulow J.Regarding “Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle”. J Vasc Surg2001; 33: 1133-1134.
37.
Hou XY, Green S, Askew CD, Barker G, Green A, Walker PJ.Skeletal muscle mitochondrial ATP production rate and walking performance in peripheral arterial disease. Clin Physiol Funct Imaging2002; 22: 226-232.
38.
Bauer TA, Brass EP, Hiatt WR.Impaired muscle oxygen utilization at the onset of exercise in peripheral arterial disease. J Vasc Surg2004; 40: 488-493.
39.
Grassi B, Pogliaghi S, Rampichini Set al.Muscle oxygenation and pulmonary gas exchange kinetics during cycling exercise on-transitions in humans. J Appl Physiol2003; 95:149-158.
40.
Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT.Exercise training for claudication. N Engl J Med2002; 347:1941-1951.
41.
Holloszy JO, Coyle EF.Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol1984; 56: 831-838.
42.
Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP.Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation1990; 81: 602-609.
43.
Brass EP, Fennessey PV, Miller LV.Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. Biochem J1986; 236:131-136.
44.
Broderick TL, Driedzic W, Paulson DJ.Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat. Mol Cell Biochem2000; 206: 151-157.
45.
Brevetti G, Chiariello M, Ferulano Get al.Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation1988; 77:767-773.
46.
Hiatt WR, Regensteiner JG, Creager MAet al.Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication. Am J Med2001; 110:616-622.
47.
Alonso JR, Cardellach F, Casademont J, Miro O.Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking. Eur Respir J2004; 23:214-218.
Greenhaff PL, Campbell-O’Sullivan SP, Constantin-Teodosiu D, Poucher SM, Roberts PA, Timmons JA.Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease. Br J Clin Pharmacol2004; 57: 237-243.
50.
Green S.Hemodynamic limitations and exercise performance in peripheral arterial disease. Clin Physiol Funct Imaging2002; 22:81-91.
51.
Regensteiner JG, Wolfel EE, Brass EPet al.Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation1993; 87:413-421.
52.
Green S, Askew C.The physiology of walking performance in peripheral arterial disease. In: Maffuli N, Chan KM, MacDonald R, Malina RM, Parker AW (eds). Sports medicine for specific ages and abilities. Edinburgh: Churchill-Livingstone, 2001: 385-393.
53.
Medbo JI, Tabata I.Relative importance of aerobic and anaerobic energy release during short-lasting exhausting bicycle exercise. J Appl Physiol1989; 67:1881-1886.
54.
Askew CD, Green S, Hou XY, Walker PJ.Physiological and symptomatic responses to cycling and walking in intermittent claudication. Clin Physiol Funct Imaging2002; 22:348-355.
55.
Olds TS, Norton KI, Craig NP.Mathematical model of cycling performance. J Appl Physiol1993; 75:730-737.
56.
Sorlie D, Myhre K.Determination of lower leg blood flow in man by thermodilution. Scand J Clin Lab Invest1977; 37: 117-124.
57.
Sorlie D, Myhre K.Effects of physical training in intermittent claudication. Scand J Clin Lab Invest1978; 38: 217-222.
58.
Sorlie D, Myhre K.Lower leg blood flow in intermittent claudication. Scand J Clin Lab Invest1978; 38:171-179.
59.
Angelides N, Nicolaides A, Needham T, Dudley H.The mechanism of calf claudication: studies of simultaneous clearance of 99Tcm from the calf and thigh. Br J Surg1978; 65:204-209.
60.
Lassen NA, Kampp M.Calf muscle blood flow during walking studied by the xe-133 method in normals and in patients with intermittent claudication. Scand J Clin Lab Invest1965; 17: 447-453.
61.
Boushel R, Langberg H, Green S, Skovgaard D, Bulow J, Kjaer M.Blood flow and oxygenation in peritendinous tissue and calf muscle during dynamic exercise in humans. J Physiol2000; 524 (Pt 1): 305-313.
62.
Pernow B, Saltin B, Wahren J, Cronestrand R, Ekestroom S.Leg blood flow and muscle metabolism in occlusive arterial disease of the leg before and after reconstructive surgery. Clin Sci Mol Med1975; 49: 265-275.
63.
Zetterquist S.The effect of active training on the nutritive blood flow in exercising ischemic legs. Scand J Clin Lab Invest1970; 25: 101-111.
64.
Pernow B, Zetterquist S.Metabolic evaluation of the leg blood flow in claudicating patients with arterial obstructions at different levels. Scand J Clin Lab Invest1968; 21:277-287.
65.
Regensteiner JG, Hargarten ME, Rutherford RB, Hiatt WR.Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology1993; 44:1-10.
66.
MacDonald MJ, Shoemaker JK, Tschakovsky ME, Hughson RL.Alveolar oxygen uptake and femoral artery blood flow dynamics in upright and supine leg exercise in humans. J Appl Physiol1998; 85: 1622-1628.
67.
Haller RG, Lewis SF.Human respiratory chain disorders: implications for muscle oxidative metabolism. In: Taylor AW, Gollnick PD, Green HJ, Ianuzzo CD, Noble EG, Sutton JR (eds). Biochemistry of exercise. Champaign: Human Kinetics, 1990: 251-264.
68.
Elander A, Sjostrom M, Lundgren F, Schersten T, Bylund-Fellenius AC.Biochemical and morphometric properties of mitochondrial populations in human muscle fibres. Clin Sci (Lond)1985; 69: 153-164.
69.
Bylund-Fellenius AC, Walker PM, Elander A, Holm S, Holm J, Schersten T.Energy metabolism in relation to oxygen partial pressure in human skeletal muscle during exercise. Biochem J1981; 200: 247-255.
70.
Lundgren F, Bennegard K, Elander A, Lundholm K, Schersten T, Bylund-Fellenius AC.Substrate exchange in human limb muscle during exercise at reduced blood flow. Am J Physiol1988; 255 (5 Pt 2): H1156-H64.
71.
Wasserman K.Critical capillary pO2 and the role of lactate production in oxyhemoglobin dissociation during exercise. Adv Exp Med Biol1999; 471:321-333.
72.
Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ.Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg1990; 4: 135-140.
73.
Zatina MA, Berkowitz HD, Gross GM, Maris JM, Chance B.31P nuclear magnetic resonance spectroscopy: noninvasive biochemical analysis of the ischemic extremity. J Vasc Surg1986; 3: 411-420.
74.
Sperl W, Skladal D, Lanznaster Net al.Polarographic studies of saponin-skinned muscle fibres in patients with mitochondrial myopathies. J Inherit Metab Dis1994; 17: 307-310.
75.
Haller RG, Vissing J.Circulatory regulation in muscle disease. In: Saltin B, Boushel R, Secher N, Mitchell J (eds). Exercise and circulation in health and disease. Champaign: Human Kinetics, 2000: 271-282.
76.
Hogan MC, Gladden LB, Grassi B, Stary CM, Samaja M.Bioenergetics of contracting skeletal muscle after partial reduction of blood flow. J Appl Physiol1998; 84: 1882-1888.
77.
Kemp GJ, Roberts N, Bimson WEet al.Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg2001; 34: 1103-1110.
78.
Grassi B.Regulation of oxygen consumption at exercise onset: is it really controversial? Exerc Sport Sci Rev2001; 29:134-138.
79.
Hughson RL, Tschakovsky ME, Houston ME.Regulation of oxygen consumption at the onset of exercise. Exerc Sport Sci Rev2001; 29: 129-133.
80.
Hiatt WR, Regensteiner JG, Wolfel EE, Ruff L, Brass EP.Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest1989; 84:1167-1173.
81.
Constantin-Teodosiu D, Cederblad G, Hultman E.PDC activity and acetylgroupaccumulationinskeletal muscle during isometric contraction. J Appl Physiol1993; 74: 1712-1718.
82.
Friolet R, Hoppeler H, Krahenbuhl S.Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J Clin Invest1994; 94: 1490-1495.
83.
Sahlin K.Muscle carnitine metabolism during incremental dynamic exercise in humans. Acta Physiol Scand1990; 138:259-262.
